Observational Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. May 28, 2024; 30(20): 2677-2688
Published online May 28, 2024. doi: 10.3748/wjg.v30.i20.2677
Table 1 Demographics of inflammatory bowel disease decedents from 2006-2021, n (%)
Overall deaths (2006-2021)
Pre-pandemic deaths (2006-2019)
Pandemic deaths (2020-2021)
Ulcerative colitis
Crohn’s disease
Ulcerative colitis
Crohn’s disease
Ulcerative colitis
Crohn’s disease
Age (yr)
≥ 6515136 (77.45)19278 (63.75)12304 (77.01)15706 (62.90)2832 (79.39)3572 (67.78)
25-644408 (22.55)10960 (36.25)3673 (22.99)9262 (37.10)735
(20.61)
1698 (32.22)
Gender
Male9805 (50.17)13317 (44.04)8087 (50.62)10951 (43.86)1718 (48.16)2366 (44.90)
Female9739 (49.83)16921 (55.96)7890 (49.38)14017 (56.14)1849 (51.84)2904 (55.10)
Race/ethnicity (not including 2021)
Hispanic726 (4.10)732 (2.66)651
(4.07)
651
(2.61)
75
(4.37)
81
(3.19)
Non-Hispanic white15740 (88.96)24661 (89.66)14249 (89.18)22448 (89.91)1491 (86.89)2213 (87.23)
Non-Hispanic black948 (5.36)1843 (6.70)841
(5.26)
1627 (6.52)107
(6.24)
216
(8.51)
Table 2 All-cause and non-coronavirus disease 2019--related age-standardized mortality rates in United States adults with inflammatory bowel disease, ulcerative colitis and Crohn’s disease overall and by age, gender, and race/ethnicity from 2006-2021
200620192020
2021
Observed all-cause
Predicted (95%CI)
Observed non-COVID
Increase (%)1
Observed all-cause
Predicted (95%CI)
Observed non-COVID
Increase (%)1
IBD1.351.471.681.37
(1.26-1.49)
1.5513.141.811.38
(1.26-1.49)
1.6318.12
UC0.510.590.680.55
(0.49-0.60)
0.6110.910.730.55
(0.50-0.60)
0.6518.18
CD0.840.891.010.91
(0.81-1.02)
0.954.401.090.97
(0.82-1.12)
0.992.06
Age
25-64 yrIBD0.530.590.680.61
(0.55-0.66)
0.656.560.710.64
(0.57-0.72)
0.640.00
UC0.140.190.210.17
(0.15-0.19)
0.2017.650.210.17
(0.15-0.19)
0.185.88
CD0.390.410.470.42
(0.37-0.47)
0.469.520.500.45
(0.38-0.52)
0.462.22
≥ 65 yrIBD4.695.035.764.95
(4.49-5.40)
5.235.666.285.07
(4.54-5.60)
5.6711.83
UC2.022.212.592.3
(2.01-2.58)
2.310.432.812.45
(2.04-2.86)
2.533.27
CD2.672.833.202.79
(2.46-3.12)
2.955.733.482.87
(2.49-3.25)
3.159.76
Sex
FemaleIBD1.281.381.611.42
(1.24-1.61)
1.484.231.761.51
(1.25-1.78)
1.595.30
UC0.430.500.600.53
(0.44-0.61)
0.541.890.680.57
(0.44-0.70)
0.605.26
CD0.850.881.020.9
(0.78-1.02)
0.955.561.090.94
(0.76-1.12)
0.995.32
MaleIBD1.441.581.761.63
(1.49-1.76)
1.630.001.871.73
(1.54-1.92)
1.68-2.89
UC0.620.700.760.68
(0.62-0.75)
0.702.940.780.7
(0.63-0.78)
0.69-1.43
CD0.830.891.000.93
(0.83-1.04)
0.941.081.101.01
(0.86-1.16)
0.99-1.98
Race/ethnicity
Non-Hispanic whiteUC0.570.680.790.71
(0.63-0.78)
0.710.00N/AN/AN/AN/A
CD0.961.081.221.12
(0.99-1.25)
1.152.68N/AN/AN/AN/A
Non-Hispanic blackUC0.240.360.420.41
(0.29-0.52)
0.39-4.88N/AN/AN/AN/A
CD0.570.580.810.55
(0.41-0.70)
0.7536.36N/AN/AN/AN/A
HispanicUC0.360.230.300.23
(0.07-0.38)
0.2613.04N/AN/AN/AN/A
CD0.220.240.300.27
(0.08-0.47)
0.270.00N/AN/AN/AN/A
Table 3 All-cause and non-coronavirus disease 2019-related age-standardized mortality rates in United States adults with inflammatory bowel disease by death place, 2006-2021
200620192020
2021
Observed all-cause
Predicted (95%CI)
Observed non-COVID
Increase (%)1
Observed all-cause
Predicted (95%CI)
Observed non-COVID
Increase (%)1
Home or on arrival0.320.470.620.46
(0.42-0.49)
0.6132.610.630.47
(0.43-0.51)
0.6129.79
Medical facility0.730.560.600.49
(0.41-0.57)
0.526.120.730.48
(0.39-0.56)
0.5922.92
Nursing home0.230.240.240.24
(0.20-0.27)
0.21-12.500.240.24
(0.20-0.28)
0.22-8.33
Hospice facility0.030.150.150.16
(0.14-0.17)
0.15-6.250.140.17
(0.15-0.18)
0.13-23.53